We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Cigna
CI
$76.1B
| $37K | 0.06% |
220
+219
| +21,900% | +$37.9K |
|
252
Cincinnati Financial
CINF
$28B
| $37K | 0.06% |
+558
| New | +$39.6K |
|
253
Capital One
COF
$124B
| $37K | 0.06% |
406
-673
| -62% | -$63.7K |
|
|
DHC
254
Diversified Healthcare Trust
DHC
$2.26B
| $37K | 0.06% |
2,070
+1,503
| +265% | +$24.9K |
|
255
Dolby
DLB
$4.72B
| $37K | 0.06% |
607
-6,073
| -91% | -$386K |
|
256
FedEx
FDX
$75B
| $37K | 0.06% |
+164
| New | +$40.6K |
|
257
General Dynamics
GD
$104B
| $37K | 0.06% |
+201
| New | +$41.2K |
|
258
Gentex
GNTX
$4.81B
| $37K | 0.06% |
+1,626
| New | +$38.6K |
|
259
Home Depot
HD
$329B
| $37K | 0.06% |
+192
| New | +$35.9K |
|
260
Ingredion
INGR
$6.37B
| $37K | 0.06% |
337
-3,008
| -90% | -$354K |
|
261
Jacobs Solutions
J
$15.9B
| $37K | 0.06% |
+712
| New | +$36.6K |
|
262
Jabil
JBL
$32.7B
| $37K | 0.06% |
+1,353
| New | +$38K |
|
263
Kraft Heinz
KHC
$30.4B
| $37K | 0.06% |
596
-3,808
| -86% | -$226K |
|
264
Landstar System
LSTR
$6.85B
| $37K | 0.06% |
343
+342
| +34,200% | +$37.6K |
|
265
McKesson
MCK
$98B
| $37K | 0.06% |
278
-1,109
| -80% | -$162K |
|
266
Altria Group
MO
$122B
| $37K | 0.06% |
+658
| New | +$37.9K |
|
267
MSC Industrial Direct
MSM
$7.05B
| $37K | 0.06% |
+441
| New | +$39.9K |
|
268
Norwegian Cruise Line
NCLH
$8.94B
| $37K | 0.06% |
+791
| New | +$41.7K |
|
269
Northern Trust
NTRS
$22.2B
| $37K | 0.06% |
+361
| New | +$38.2K |
|
270
Nu Skin
NUS
$248M
| $37K | 0.06% |
+479
| New | +$37.1K |
|
271
Old Dominion Freight Line
ODFL
$49B
| $37K | 0.06% |
+753
| New | +$37.4K |
|
272
Old Republic International
ORI
$10.2B
| $37K | 0.06% |
+1,865
| New | +$39K |
|
273
PNC Financial Services
PNC
$100B
| $37K | 0.06% |
+276
| New | +$40.3K |
|
274
Ralph Lauren
RL
$22.2B
| $37K | 0.06% |
+291
| New | +$35.3K |
|
275
Republic Services
RSG
$66.7B
| $37K | 0.06% |
544
-3,250
| -86% | -$219K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.